KalVista Pharmaceuticals Inc (KALV) poses a Brand-New Opportunity for Investors with beta value of 0.40
KalVista Pharmaceuticals Inc (NASDAQ: KALV) established initial surge of 3.02% at $11.61, as the Stock market unbolted on Wednesday, before settling in for the price